MRNA Moderna
Nasdaq · SEC CIK 1682852 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $64.63M 14 sales by 6 insiders
- Filings on record
- 574 since 2021-07-02, latest 2026-09-16 16:48
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bancel Stephane | CEO, Dir | — | $28.72M |
| Hoge Stephen | Pres | — | $28.43M |
| Mock James M | CFO | — | $4.69M |
| Klinger Shannon Thyme | CLO | — | $1.39M |
| AFEYAN NOUBAR | Dir | — | $1.14M |
| Hussain Abbas | Dir | — | $278.9K |
| Horning Sandra | Dir | — | — |
| NABEL ELIZABETH G | Dir | — | — |
| Rubenstein David M. | Dir | — | — |
| Nader Francois | Dir | — | — |
Transactions 1,002
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-16 16:48 | 2026-09-14+ | MRNA | Hoge Stephen | Pres | M - OptEx | $12.21 | +152.9K | 1.60M | +11% | +$1.87M |
| DMT | 2026-09-16 16:48 | 2026-09-14+ | MRNA | Hoge Stephen | Pres | S - Sale+OE | $145.10 | -80.6K | 1.56M | -5% | -$11.69M |
| DT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Mock James M | CFO | M - OptEx | $30.96 | +19.8K | 94.2K | +27% | +$614.1K |
| DMT | 2026-09-14 16:25 | 2026-09-10 | MRNA | Mock James M | CFO | S - Sale+OE | $134.49 | -34.8K | 59.4K | -37% | -$4.69M |
| D | 2026-09-08 17:02 | 2026-09-04 | MRNA | Mock James M | CFO | M - OptEx | — | +11.8K | 80.1K | +17% | — |
| D | 2026-09-08 17:02 | 2026-09-04 | MRNA | Mock James M | CFO | F - Tax | $148.87 | -5,704 | 74.4K | -7% | -$849.2K |
| D | 2026-09-08 16:57 | 2026-09-04 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +11.8K | 87.0K | +16% | — |
| D | 2026-09-08 16:57 | 2026-09-04 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $148.87 | -5,704 | 81.3K | -7% | -$849.2K |
| DMT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $30.96 | +5,637 | 76.3K | +8% | +$174.5K |
| DT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $139.95 | -3,471 | 74.1K | -4% | -$485.8K |
| DT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $140.34 | -1,048 | 75.2K | -1% | -$147.1K |
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Mock James M | CFO | M - OptEx | — | +2,475 | 69.5K | +4% | — |
| D | 2026-09-03 16:52 | 2026-09-01 | MRNA | Mock James M | CFO | F - Tax | $140.34 | -1,197 | 68.3K | -2% | -$168.0K |
| D | 2026-09-03 16:50 | 2026-09-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +9,283 | 1.49M | +0.6% | — |
| D | 2026-09-03 16:50 | 2026-09-01 | MRNA | Hoge Stephen | Pres | F - Tax | $140.34 | -4,489 | 1.49M | -0.3% | -$630.0K |
| DM | 2026-08-31 16:51 | 2026-08-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,048 | 1.49M | +0.1% | — |
| DM | 2026-08-31 16:51 | 2026-08-27+ | MRNA | Hoge Stephen | Pres | F - Tax | $147.60 | -991 | 1.48M | -0.1% | -$146.3K |
| DM | 2026-08-31 16:37 | 2026-08-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,103 | 74.3K | +2% | — |
| DM | 2026-08-31 16:37 | 2026-08-27+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $147.60 | -535 | 74.1K | -0.7% | -$79.0K |
| DM | 2026-08-31 16:34 | 2026-08-27+ | MRNA | Mock James M | CFO | M - OptEx | — | +1,103 | 67.2K | +2% | — |
| DM | 2026-08-31 16:34 | 2026-08-27+ | MRNA | Mock James M | CFO | F - Tax | $147.60 | -535 | 67.0K | -0.8% | -$79.0K |
| DMT | 2026-08-07 16:11 | 2026-08-05+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $19.15 | +751.7K | 6.44M | +13% | +$14.40M |
| DMT | 2026-08-07 16:11 | 2026-08-05 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $57.52 | -499.2K | 6.19M | -7% | -$28.72M |
| DMT | 2026-07-16 16:45 | 2026-07-15 | MRNA | Hoge Stephen | Pres | M - OptEx | $19.15 | +53.3K | 1.54M | +4% | +$1.02M |
| DT | 2026-07-16 16:45 | 2026-07-15 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $67.60 | -53.3K | 1.48M | -3% | -$3.61M |
| D | 2026-07-06 16:30 | 2026-07-02 | MRNA | Mock James M | CFO | M - OptEx | — | +1,452 | 67.1K | +2% | — |
| D | 2026-07-06 16:30 | 2026-07-02 | MRNA | Mock James M | CFO | F - Tax | $72.50 | -703 | 66.4K | -1% | -$51.0K |
| DMT | 2026-06-17 16:10 | 2026-06-15 | MRNA | Hoge Stephen | Pres | M - OptEx | $19.15 | +53.3K | 1.54M | +4% | +$1.02M |
| DT | 2026-06-17 16:10 | 2026-06-15 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $51.37 | -53.3K | 1.48M | -3% | -$2.74M |
| DMT | 2026-06-08 16:34 | 2026-06-04+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $30.96 | +15.3K | 79.3K | +24% | +$472.7K |
| DT | 2026-06-08 16:34 | 2026-06-04 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $50.00 | -3,471 | 67.5K | -5% | -$173.6K |
| DT | 2026-06-08 16:34 | 2026-06-05 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $51.59 | -5,705 | 73.6K | -7% | -$294.3K |
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Mock James M | CFO | M - OptEx | — | +11.8K | 71.4K | +20% | — |
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Mock James M | CFO | F - Tax | $51.59 | -5,705 | 65.7K | -8% | -$294.3K |
| D | 2026-06-03 16:21 | 2026-06-01 | MRNA | Mock James M | CFO | M - OptEx | — | +2,475 | 60.8K | +4% | — |
| D | 2026-06-03 16:21 | 2026-06-01 | MRNA | Mock James M | CFO | F - Tax | $47.19 | -1,197 | 59.6K | -2% | -$56.5K |
| D | 2026-06-03 16:19 | 2026-06-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +2,165 | 68.5K | +3% | — |
| D | 2026-06-03 16:19 | 2026-06-01 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $47.19 | -1,047 | 67.5K | -2% | -$49.4K |
| D | 2026-06-03 16:16 | 2026-06-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +9,282 | 1.49M | +0.6% | — |
| D | 2026-06-03 16:16 | 2026-06-01 | MRNA | Hoge Stephen | Pres | F - Tax | $47.19 | -4,488 | 1.48M | -0.3% | -$211.8K |
| DM | 2026-05-29 17:13 | 2026-05-27+ | MRNA | Mock James M | CFO | M - OptEx | — | +1,101 | 58.5K | +2% | — |
| DM | 2026-05-29 17:13 | 2026-05-27+ | MRNA | Mock James M | CFO | F - Tax | $47.20 | -533 | 58.3K | -0.9% | -$25.2K |
| DM | 2026-05-29 17:10 | 2026-05-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,101 | 66.5K | +2% | — |
| DM | 2026-05-29 17:10 | 2026-05-27+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $47.20 | -533 | 66.3K | -0.8% | -$25.2K |
| DM | 2026-05-29 17:04 | 2026-05-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,047 | 1.48M | +0.1% | — |
| DM | 2026-05-29 17:04 | 2026-05-27+ | MRNA | Hoge Stephen | Pres | F - Tax | $47.20 | -990 | 1.48M | -0.1% | -$46.7K |
| DI | 2026-05-22 19:00 | 2026-05-21 | MRNA | AFEYAN NOUBAR | Dir | M - OptEx | $19.15 | +9,263 | 13.2K | +236% | +$177.4K |
| DI | 2026-05-22 19:00 | 2026-05-21 | MRNA | AFEYAN NOUBAR | Dir | S - Sale+OE | $46.84 | -9,263 | 3,924 | -70% | -$433.9K |
| DMT | 2026-05-18 16:57 | 2026-05-15 | MRNA | Hoge Stephen | Pres | M - OptEx | $19.15 | +53.3K | 1.53M | +4% | +$1.02M |
| DT | 2026-05-18 16:57 | 2026-05-15 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $48.40 | -53.3K | 1.48M | -3% | -$2.58M |
| D | 2026-05-04 17:39 | 2026-04-30 | MRNA | Horning Sandra | Dir | M - OptEx | — | +16.2K | 18.6K | +690% | — |
| D | 2026-05-04 17:36 | 2026-04-30 | MRNA | Rubenstein David M. | Dir | M - OptEx | — | +8,116 | 9,643 | +531% | — |
| DT | 2026-05-04 17:25 | 2026-04-30 | MRNA | Hussain Abbas | Dir | M - OptEx | — | +16.2K | 17.7K | +1,071% | — |
| DT | 2026-05-04 17:25 | 2026-05-01 | MRNA | Hussain Abbas | Dir | S - Sale+OE | $46.63 | -5,682 | 12.1K | -32% | -$265.0K |
| D | 2026-05-04 16:59 | 2026-04-30 | MRNA | NABEL ELIZABETH G | Dir | M - OptEx | — | +16.2K | 19.3K | +526% | — |
| D | 2026-05-04 16:48 | 2026-04-30 | MRNA | Nader Francois | Dir | M - OptEx | — | +12.2K | 32.8K | +59% | — |
| D | 2026-05-04 16:44 | 2026-04-30 | MRNA | Tallett Elizabeth E | Dir | M - OptEx | — | +4,058 | 4,761 | +577% | — |
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Mock James M | CFO | M - OptEx | — | +1,453 | 58.5K | +3% | — |
| D | 2026-04-06 16:45 | 2026-04-02 | MRNA | Mock James M | CFO | F - Tax | $50.03 | -703 | 57.7K | -1% | -$35.2K |
| D | 2026-03-06 | 2026-03-05 | MRNA | Mock James M | CFO | M - OptEx | — | +11.8K | 62.7K | +23% | — |
| D | 2026-03-06 | 2026-03-05 | MRNA | Mock James M | CFO | F - Tax | $57.80 | -5,704 | 57.0K | -9% | -$329.7K |
| D | 2026-03-06 | 2026-03-05 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +11.8K | 71.5K | +20% | — |
| D | 2026-03-06 | 2026-03-05 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $57.80 | -5,704 | 65.8K | -8% | -$329.7K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +39.8K | 1.46M | +3% | — |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Hoge Stephen | Pres | F - Tax | $51.71 | -19.3K | 1.48M | -1% | -$995.9K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Mock James M | CFO | F - Tax | $51.71 | -5,323 | 50.9K | -9% | -$275.3K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Mock James M | CFO | M - OptEx | — | +11.0K | 46.2K | +31% | — |
| D | 2026-03-03 | 2026-03-02 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $52.29 | -13.9K | 59.7K | -19% | -$726.0K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $51.71 | -4,837 | 54.8K | -8% | -$250.1K |
| DM | 2026-03-03 | 2026-02-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $30.96 | +23.9K | 55.0K | +77% | +$739.4K |
| DM | 2026-02-25 | 2026-02-23 | MRNA | Hoge Stephen | Pres | M - OptEx | $19.15 | +160.0K | 1.62M | +11% | +$3.06M |
| D | 2026-02-25 | 2026-02-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $48.84 | -160.0K | 1.46M | -10% | -$7.81M |
| 2026-02-13 | 2026-02-11 | MRNA | Mock James M | CFO | F - Tax | $41.99 | -1,278 | 45.2K | -3% | -$53.7K | |
| 2026-02-13 | 2026-02-11 | MRNA | Mock James M | CFO | A - Grant | $0.00 | +2,630 | 46.5K | +6% | $0 | |
| 2026-02-13 | 2026-02-11 | MRNA | Klinger Shannon Thyme | CLO | A - Grant | $0.00 | +2,630 | 55.9K | +5% | $0 | |
| 2026-02-13 | 2026-02-11 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $41.99 | -1,334 | 54.5K | -2% | -$56.0K | |
| 2026-02-13 | 2026-02-11 | MRNA | Bancel Stephane | CEO, Dir | F - Tax | $41.99 | -5,450 | 6.19M | -0.1% | -$228.8K | |
| 2026-02-13 | 2026-02-11 | MRNA | Bancel Stephane | CEO, Dir | A - Grant | $0.00 | +11.3K | 6.19M | +0.2% | $0 | |
| 2026-02-13 | 2026-02-11 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +4,884 | 1.46M | +0.3% | $0 | |
| 2026-02-13 | 2026-02-11 | MRNA | Hoge Stephen | Pres | F - Tax | $41.99 | -2,362 | 1.46M | -0.2% | -$99.2K | |
| D | 2026-01-06 | 2026-01-05 | MRNA | Mock James M | CFO | M - OptEx | — | +1,452 | 44.7K | +3% | — |
| D | 2026-01-06 | 2026-01-05 | MRNA | Mock James M | CFO | F - Tax | $30.86 | -780 | 43.9K | -2% | -$24.1K |
| D | 2025-12-15 | 2025-12-11 | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $10.90 | +688.1K | 6.18M | +13% | +$7.50M |
| DI | 2025-12-15 | 2025-12-11 | MRNA | AFEYAN NOUBAR | Dir | M - OptEx | $10.90 | +23.9K | 27.8K | +608% | +$260.0K |
| DI | 2025-12-15 | 2025-12-11 | MRNA | AFEYAN NOUBAR | Dir | S - Sale+OE | $29.49 | -23.9K | 3,924 | -86% | -$703.4K |
| 2025-12-11 | 2025-12-09 | MRNA | Hussain Abbas | Dir | S - Sale | $27.60 | -504 | 1,515 | -25% | -$13.9K | |
| D | 2025-12-08 | 2025-12-05 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +47.2K | 76.0K | +164% | — |
| D | 2025-12-08 | 2025-12-05 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $25.49 | -22.8K | 53.2K | -30% | -$581.6K |
| D | 2025-12-08 | 2025-12-05 | MRNA | Mock James M | CFO | M - OptEx | — | +47.2K | 66.0K | +251% | — |
| D | 2025-12-08 | 2025-12-05 | MRNA | Mock James M | CFO | F - Tax | $25.49 | -22.8K | 43.2K | -35% | -$581.6K |
| D | 2025-12-02 | 2025-12-01 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $25.98 | -113 | 28.9K | -0.4% | -$2,936 |
| D | 2025-12-02 | 2025-12-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +233 | 29.0K | +0.8% | — |
| D | 2025-12-02 | 2025-12-01 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +652 | 1.46M | +0.0% | — |
| D | 2025-12-02 | 2025-12-01 | MRNA | Hoge Stephen | Pres | F - Tax | $25.98 | -316 | 1.45M | -0.0% | -$8,210 |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +1,102 | 28.9K | +4% | — |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $24.83 | -534 | 28.7K | -2% | -$13.3K |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Mock James M | CFO | F - Tax | $24.83 | -534 | 18.7K | -3% | -$13.3K |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Mock James M | CFO | M - OptEx | — | +1,102 | 19.0K | +6% | — |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Hoge Stephen | Pres | F - Tax | $24.83 | -990 | 1.45M | -0.1% | -$24.6K |
| DM | 2025-12-01 | 2025-11-26+ | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,047 | 1.45M | +0.1% | — |
Purchase Sale Sale after option exercise All abbreviations